Novo CEO pressed by Senate to cut charges of weight problems, diabetes prescription drugs CEO Lars Fruergaard Jørgensen advised lawmakers the corporate would take into consideration new talks with insurers in regards to the list selling prices of Wegovy and copyright if they pledge to help keep the medicines on their formularies.Earlier this summe… Read More